1. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G, Tan PL, Souied EH, Richardson AJ, Merriam JE, Buitendijk GH, Reynolds R, Raychaudhuri S, Chin KA, Sobrin L, Evangelou E, Lee PH, Lee AY, Leveziel N, Zack DJ, Campochiaro B, Campochiaro P, Smith RT, Barile GR, Guymer RH, Hogg R, Chakravarthy U, Robman LD, Gustafsson O, Sigurdsson H, Ortmann W, Behrens TW, Stefansson K, Uitterlinden AG, van Duijn CM, Vingerling JR, Klaver CC, Allikmets R, Brantley MA, Baird PN, Katsanis N, Thorsteinsdottir U, Ioannidis JP, Daly MJ, Graham RR, Seddon JM (2011) Hum Mol Genet 20(18): 3699-709
    › Primary publication · 21665990 (PubMed) · PMC3159552 (PubMed Central)
  2. The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration. Lee AY, Kulkarni M, Fang AM, Edelstein S, Osborn MP, Brantley MA (2010) Br J Ophthalmol 94(7): 915-7
    › Primary publication · 20606025 (PubMed) · PMC3655725 (PubMed Central)
  3. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM (2010) Proc Natl Acad Sci U S A 107(16): 7395-400
    › Primary publication · 20385826 (PubMed) · PMC2867697 (PubMed Central)
  4. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA (2009) Mol Vis : 2710-9
    › Primary publication · 20019880 (PubMed) · PMC2793900 (PubMed Central)
  5. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA (2009) Br J Ophthalmol 93(5): 610-3
    › Primary publication · 19091853 (PubMed) · PMC3490485 (PubMed Central)
  6. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma. Hegedus B, Hughes FW, Garbow JR, Gianino S, Banerjee D, Kim K, Ellisman MH, Brantley MA, Gutmann DH (2009) J Neuropathol Exp Neurol 68(5): 542-51
    › Primary publication · 19525901 (PubMed) · PMC2746323 (PubMed Central)
  7. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Brantley MA, Edelstein SL, King JM, Plotzke MR, Apte RS, Kymes SM, Shiels A (2009) Eye (Lond) 23(3): 626-31
    › Primary publication · 18292785 (PubMed) · PMC5531276 (PubMed Central)
  8. Neurturin-mediated ret activation is required for retinal function. Brantley MA, Jain S, Barr EE, Johnson EM, Milbrandt J (2008) J Neurosci 28(16): 4123-35
    › Primary publication · 18417692 (PubMed) · PMC2704905 (PubMed Central)
  9. CFH and LOC387715/ARMS2 genotypes and antioxidants and zinc therapy for age-related macular degeneration. Lee AY, Brantley MA (2008) Pharmacogenomics 9(10): 1547-50
    › Primary publication · 18855541 (PubMed)
  10. Peripapillary Hemorrhage. Knopf HL, Carter K, Council MD, Brantley MA (2007) Compr Ophthalmol Update 8(1): 53-4
    › Primary publication · 17394760 (PubMed)